153
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors?

, , , , &
Pages S37-S44 | Received 14 Feb 2010, Accepted 09 Jun 2010, Published online: 10 Nov 2010

References

  • O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009; 373: 1891–1904.
  • Goss CH, Burns JL. Exacerbations in cystic fibrosis 1: epidemiology and pathogenesis. Thorax 2007; 62: 360–367.
  • Koch C, Hoiby N. Diagnosis and treatment of cystic fibrosis. Respiration. 2000; 67: 239–247.
  • Emerson J, Rosenfeld M, McNamara S, . Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002; 34: 91–100.
  • Pihet M, Carrere J, Cimon B, . Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis-a review. Med Mycol 2009; 47: 387–397.
  • Bouchara JP, Hsieh HY, Croquefer S, . Development of an oligonucleotide array for direct detection of fungi in sputum samples from patients with cystic fibrosis. J Clin Microbiol 2009; 47: 142–152.
  • Bargon J, Dauletbaev N, Kholer B, . Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonisation in adult cystic fibrosis patients. Respir Med 1999; 93: 835–838.
  • Lake FR, Tribe AE, McAleer R, Froudist J, Thompson PJ. Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus. Thorax 1990; 45: 489–491.
  • Guignard S, Hubert D, Dupont B, . Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient. J Cyst Fibros 2008; 7: 89–91.
  • Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18: 44–69.
  • Symoens F, Knoop C, Schrooyen M, . Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant 2006; 25: 603–607.
  • Husain S, Munoz P, Forrest G, . Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005; 40: 89–99.
  • Orens JB, Estenne M, Arcasoy S, . International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 745–755.
  • Cortez KJ, Roilides E, Quiroz-Telles F, . Infections caused by Scedosporium spp. Clin Microbiol Rev 2008; 21: 157–197.
  • Cimon B, Carrere J, Vinatier JF, . Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000; 19: 53–56.
  • Williamson EC, Speers D, Arthur IH, Harnett G, Ryan G, Inglis TJ. Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease. J Clin Microbiol 2001; 39: 47–50.
  • Rainer J, Kaltseis J, de Hoog SG, Summerbell RC. Efficacy of a selective isolation procedure for members of the Pseudallescheria boydii complex. Ant Van Leeuwenhoek 2008; 93: 315–322.
  • Gilgado F, Cano J, Gene J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol 2005; 43: 4930–4942.
  • Gilgado F, Cano J, Gene J, Sutton DA, Guarro J. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol 2008; 46: 766–771.
  • Blyth CC, Harun A, Middleton PG, . Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media. J Clin Microbiol 2010; 48: 314–316.
  • Miller MR, Hankinson J, Brusasco V, . Standardisation of spirometry. Eur Respir J 2005; 26: 319–338.
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179–187.
  • Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of Clinical Microbiology. Washington: American Society for Microbiology, 2007.
  • de Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of Clinical Fungi. 2nd. Utrecht, The Netherlands: Centraalbureau voor Schimmelcultures, 2000: 305–310, 899–901.
  • Delhaes L, Harun A, Chen SC, . Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum. Emerg Infect Dis 2008; 14: 282–290.
  • Flume PA, O’Sullivan BP, Robinson KA, . Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007; 176: 957–969.
  • De Pauw B, Walsh TJ, Donnelly JP, . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–1821.
  • Horre R, Marklein G, Siekmeier R, Nidermajer S, Reiffert SM. Selective isolation of Pseudallescheria and Scedosporium species from respiratory tract specimens of cystic fibrosis patients. Respiration 2009; 77: 320–324.
  • Berenguer J, Rodriguez-Tudela JL, Richard C, . Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium prolificans Spanish Study Group. Medicine 1997; 76: 256–265.
  • Idigoras P, Perez-Trallero E, Pineiro L, . Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999. Clin Infect Dis 2001; 32: E158–E165.
  • Heath C, Slavin M, Sorrell TC, . Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Inf 2009; 15: 689–693.
  • Cano J, Guarro J, Mayayo E, Fernandez-Ballart J. Experimental infection with Scedosporium inflatum. J Med Vet Mycol 1992; 30: 413–420.
  • Gilgado F, Cano J, Gene J, Serena C, Guarro J. Different virulence of the species of the Pseudallescheria boydii complex. Med Mycol 2009; 47: 371–374.
  • Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology 2007; 153: 917–923.
  • Burns JL, Van Dalfsen JM, Shawar RM, . Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis 1999; 179: 1190–1196.
  • Mastella G, Rainisio M, Harms HK, . Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 2000; 16: 464–741.
  • Amin R, Dupuis A, Aaron SD, Ratjen F. The Effect of cinfection with Aspergillus fumigatus on lung function and hospitalisation in cystic fibrosis patients. Chest 2010; 137: 171–176.
  • Sole A, Salavert M. Fungal infections after lung transplantation. Transplant Rev 2008; 22: 89–104.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.